Changes in Medical and Surgical Treatments of Glaucoma between 1997 and 2000 in France

Abstract

Purpose

To analyze quantitative changes in glaucoma treatment strategies between 1997 and 2000 in France.

Methods

Numbers of ab externo trabeculectomies and other glaucoma surgeries were extracted from the national database of the French Diagnosis Related Group system, which includes data for both public and private hospitals. Mean lengths of stay and hospital costs were estimated using national cost scales published by the French Ministry of Health. Numbers of patients treated per year with latanoprost, brimonidine, or the fixed combination of dorzolamide + timolol were estimated from drug unit sales using defined daily doses for each drug.

Results

Between 1997 and 2000, the number of patients treated with a glaucoma drug increased from 410,000 to 734,000 patients per year. This increase was associated with the introduction of three new glaucoma drugs: 245,000 patients received latanoprost (71.0%), brimonidine (28.8%), or the fixed combination of dorzolamide + timolol (0.2%). During the same period, the surgery rate in patients receiving medical treatment declined by 47%, from 5.9% to 3.1%. The total number of glaucoma interventions declined by 4.6% (-12% in public hospitals and 0% in private hospitals). This relative stability resulted mostly from a shift from trabeculectomies to other procedures, mainly to new filtering procedures in private hospitals.

Conclusions

Between 1997 and 2000, new glaucoma drugs, primarily latanoprost and brimonidine, improved intraocular pressure control and delayed surgery, reducing the glaucoma procedure rate in patients receiving glaucoma-related medical treatment by 47%.

Keywords

Brimonidine Dorzolamide Glaucoma Latanoprost Surgery Timolol Trabeculectomy

Get full access to this article

View all access options for this article.

References

Alward

W.L.M.

. Medical management of glaucoma. N Engl J Med 1998; 339: 1298–307.

Kass

M.A.

Heuer

D.K.

Higginbotham

E.J.

The Ocular Hypertension Treatment Study. A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Arch Ophthalmol 2002; 120: 701–13.

The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130: 429–40.

Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998; 126: 487–97.

Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998; 126: 498–505.

Mao

L.K.

Stewart

W.C.

Shields

M.B.

. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 1991; 111: 51–5.

European Glaucoma Society. Principes du traitement et options thérapeutiques. In: Guide pour les glaucomes. Savona, Italy: DOGMA® S.r.l., 1999; 81–110.

Béchetoille

. Chirurgie des glaucomes chroniques de l'adulte. In: Les Glaucomes. Vol 2. Paris, France: Jappere-nard, 2000; 279–324.

Hamard

Lachkar

. La chirurgie filtrante non-perforante: évolution du concept, réalisation, résultats. J Fr Ophtalmol 2002; 25: 527–36.

10.

Ambresin

Shaarawy

Mermoud

. Deep sclerectomy with collagen implant in one eye compared with trabeculectomy in the other eye of the same patient. J Glaucoma 2002; 11: 214–20.

11.

Shingleton

B.J.

Richter

C.U.

Dharma

S.K.

Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study.

Ophthalmology 1993; 100: 1324–9.

12.

Site officiel du Programme de Médicalisation des Systèmes d'Information (PMSI). Available at: www.atih.sante.fr/pmsi. Accessed January 15, 2003.

13.

Bateman

D.N.

Clark

Azuara-Blanco

Bain

Forrest

. The impact of new drugs on management of glaucoma in Scotland: observational study. BMJ 2001; 323: 1401–2.

14.

Bateman

D.N.

Clark

Azuara-Blanco

Bain

Forrest

. The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care. Br J Ophthalmol 2002; 86: 551–4.

15.

Paikal

Coleman

A.L.

. Trends in glaucoma surgery incidence and reimbursement for physician services in the Medicare population from 1995 to 1998. Ophthalmology 2002; 109: 1372–6.